UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat liver cancer
Disease control OngoingThis study is testing whether a new drug called pevonedistat can help control advanced bile duct cancer that starts in the liver. It is being tested alone and in combination with two standard chemotherapy drugs (carboplatin and paclitaxel) in about 40 patients whose cancer has wo…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for Tough-to-Treat bile duct cancers
Disease control OngoingThis study is for people with advanced bile duct, gallbladder, or liver bile duct cancer that has worsened after initial treatment. It tests whether adding a targeted pill called binimetinib to standard chemotherapy (FOLFOX) helps patients live longer and better control the cance…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC